Luuk Dekker, Jasper D Daems, Mariam Ali, Martijne H C Duvekot, Truc My T Nguyen, Esmee Venema, Marcel D J Durieux, Erik W van Zwet, Walid Moudrous, Ido R van den Wijngaard, Henk Kerkhoff, Hester F Lingsma, Diederik W J Dippel, Marieke J H Wermer, Bob Roozenbeek, Nyika D Kruyt
{"title":"Prehospital Large-Vessel Occlusion Stroke Detection Scales: A Pooled Individual Patient Data Analysis of 2 Prospective Cohorts.","authors":"Luuk Dekker, Jasper D Daems, Mariam Ali, Martijne H C Duvekot, Truc My T Nguyen, Esmee Venema, Marcel D J Durieux, Erik W van Zwet, Walid Moudrous, Ido R van den Wijngaard, Henk Kerkhoff, Hester F Lingsma, Diederik W J Dippel, Marieke J H Wermer, Bob Roozenbeek, Nyika D Kruyt","doi":"10.1212/WNL.0000000000213570","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Various prehospital scales have been developed to detect patients with anterior-circulation large-vessel occlusion (aLVO) ischemic stroke to enable direct transportation to a thrombectomy-capable stroke center. To guide implementation, a head-to-head comparison of aLVO stroke detection scales is needed to determine which scale is most useful for prehospital triage in different regional contexts. We aimed to systematically identify and compare these scales.</p><p><strong>Methods: </strong>Published prehospital aLVO stroke scales were identified with a systematic literature search. Scales were reconstructed from individual patient data of 2 large prospective observational cohort studies conducted between 2018 and 2019, the Leiden Prehospital Stroke Study and PREhospital triage of patients with suspected STrOke symptoms study. Both studies included consecutive adult patients suspected by paramedics of having a stroke within 6 hours of symptom onset, from 4 Dutch ambulance regions, encompassing 15 stroke centers and serving 3.7 million people. All data used for the reconstruction of scales were acquired by paramedics in the field before hospital arrival. Scales' diagnostic performance to detect aLVO stroke was compared with the area under the receiver operating characteristic curve (AUROC) of the full scale and sensitivity and specificity at the scales' original cut-point. Decision curve analysis was used to evaluate harm-benefit trade-offs between delaying IV thrombolysis and expediting endovascular thrombectomy with direct transportation of patients to a thrombectomy-capable center.</p><p><strong>Results: </strong>We identified 63 aLVO scales, of which 14 could be reconstructed. Of 2,358 included patients (mean age 70 years; 47% female), 231 (9.8%) had aLVO stroke. The AUROC was highest for Rapid Arterial oCclusion Evaluation (RACE) (0.81, 95% CI 0.78-0.84), Los Angeles Motor Scale (LAMS) (0.80, 95% CI 0.77-0.83), Gaze-Face-Arm-Speech-Time (G-FAST) (0.80, 95% CI 0.77-0.83), and modified Gaze-Face-Arm-Speech-Time (mG-FAST) (0.79, 95% CI 0.76-0.82). The Emergency Medical Stroke Assessment had highest sensitivity (85%, 95% CI 80%-90%) but lowest specificity (58%, 95% CI 56%-61%) while Cincinnati Prehospital Stroke Scale with an adjusted cut-point of 3 + gaze had highest specificity (94%, 95% CI 93%-95%) but lowest sensitivity (35%, 95% CI 29%-41%). In decision curve analysis, RACE had the highest benefit across a clinically reasonable range of harm-benefit trade-offs.</p><p><strong>Discussion: </strong>RACE, LAMS, G-FAST, and mG-FAST are the best-performing scales, with RACE being preferred in most triage settings. Our findings may support policymakers with implementing a scale suitable for their region.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"104 9","pages":"e213570"},"PeriodicalIF":7.7000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11984832/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/WNL.0000000000213570","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Various prehospital scales have been developed to detect patients with anterior-circulation large-vessel occlusion (aLVO) ischemic stroke to enable direct transportation to a thrombectomy-capable stroke center. To guide implementation, a head-to-head comparison of aLVO stroke detection scales is needed to determine which scale is most useful for prehospital triage in different regional contexts. We aimed to systematically identify and compare these scales.
Methods: Published prehospital aLVO stroke scales were identified with a systematic literature search. Scales were reconstructed from individual patient data of 2 large prospective observational cohort studies conducted between 2018 and 2019, the Leiden Prehospital Stroke Study and PREhospital triage of patients with suspected STrOke symptoms study. Both studies included consecutive adult patients suspected by paramedics of having a stroke within 6 hours of symptom onset, from 4 Dutch ambulance regions, encompassing 15 stroke centers and serving 3.7 million people. All data used for the reconstruction of scales were acquired by paramedics in the field before hospital arrival. Scales' diagnostic performance to detect aLVO stroke was compared with the area under the receiver operating characteristic curve (AUROC) of the full scale and sensitivity and specificity at the scales' original cut-point. Decision curve analysis was used to evaluate harm-benefit trade-offs between delaying IV thrombolysis and expediting endovascular thrombectomy with direct transportation of patients to a thrombectomy-capable center.
Results: We identified 63 aLVO scales, of which 14 could be reconstructed. Of 2,358 included patients (mean age 70 years; 47% female), 231 (9.8%) had aLVO stroke. The AUROC was highest for Rapid Arterial oCclusion Evaluation (RACE) (0.81, 95% CI 0.78-0.84), Los Angeles Motor Scale (LAMS) (0.80, 95% CI 0.77-0.83), Gaze-Face-Arm-Speech-Time (G-FAST) (0.80, 95% CI 0.77-0.83), and modified Gaze-Face-Arm-Speech-Time (mG-FAST) (0.79, 95% CI 0.76-0.82). The Emergency Medical Stroke Assessment had highest sensitivity (85%, 95% CI 80%-90%) but lowest specificity (58%, 95% CI 56%-61%) while Cincinnati Prehospital Stroke Scale with an adjusted cut-point of 3 + gaze had highest specificity (94%, 95% CI 93%-95%) but lowest sensitivity (35%, 95% CI 29%-41%). In decision curve analysis, RACE had the highest benefit across a clinically reasonable range of harm-benefit trade-offs.
Discussion: RACE, LAMS, G-FAST, and mG-FAST are the best-performing scales, with RACE being preferred in most triage settings. Our findings may support policymakers with implementing a scale suitable for their region.
背景和目的:各种院前量表已经开发出来,用于检测前循环大血管闭塞(aLVO)缺血性卒中患者,以便直接运送到具有血栓切除术能力的卒中中心。为了指导实施,需要对aLVO脑卒中检测量表进行逐项比较,以确定哪种量表在不同地区的院前分诊中最有用。我们的目标是系统地识别和比较这些量表。方法:通过系统的文献检索对院前aLVO卒中量表进行鉴定。根据2018年至2019年进行的两项大型前瞻性观察队列研究、莱顿院前卒中研究和疑似卒中症状患者院前分诊研究的个体患者数据重建量表。这两项研究都纳入了连续的成年患者,这些患者在症状出现6小时内被护理人员怀疑患有中风,来自荷兰4个救护车区,包括15个中风中心,为370万人提供服务。用于重建量表的所有数据均由护理人员在到达医院前在现场获得。将量表对aLVO脑卒中的诊断性能与全量表的受试者工作特征曲线下面积(AUROC)和量表原始切点的敏感性和特异性进行比较。决策曲线分析用于评估延迟静脉溶栓和加速血管内取栓(直接将患者运送到具有取栓能力的中心)之间的利弊权衡。结果:共鉴定出63个aLVO量表,其中14个可以重建。在2358例纳入的患者中(平均年龄70岁;47%女性),231例(9.8%)发生aLVO卒中。AUROC最高的是快速动脉闭塞评价(RACE) (0.81, 95% CI 0.78-0.84)、洛杉矶运动量表(rams) (0.80, 95% CI 0.77-0.83)、注视-面部-手臂-言语-时间(G-FAST) (0.80, 95% CI 0.77-0.83)和改良的注视-面部-手臂-言语-时间(mG-FAST) (0.79, 95% CI 0.76-0.82)。急诊卒中评估灵敏度最高(85%,95% CI 80%-90%),但特异性最低(58%,95% CI 56%-61%),而调整切割点为3 +注视的辛辛那提院前卒中量表特异性最高(94%,95% CI 93%-95%),但灵敏度最低(35%,95% CI 29%-41%)。在决策曲线分析中,RACE在临床合理的损益权衡范围内具有最高的效益。讨论:RACE、LAMS、G-FAST和mG-FAST是表现最好的量表,在大多数分诊设置中首选RACE。我们的研究结果可能会支持政策制定者实施适合其地区的规模。
期刊介绍:
Neurology, the official journal of the American Academy of Neurology, aspires to be the premier peer-reviewed journal for clinical neurology research. Its mission is to publish exceptional peer-reviewed original research articles, editorials, and reviews to improve patient care, education, clinical research, and professionalism in neurology.
As the leading clinical neurology journal worldwide, Neurology targets physicians specializing in nervous system diseases and conditions. It aims to advance the field by presenting new basic and clinical research that influences neurological practice. The journal is a leading source of cutting-edge, peer-reviewed information for the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views, Historical Neurology, NeuroImages, Humanities, Letters, and position papers from the American Academy of Neurology. The online version is considered the definitive version, encompassing all available content.
Neurology is indexed in prestigious databases such as MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar.